Fraser J. Wilkes

941 total citations
7 papers, 695 citations indexed

About

Fraser J. Wilkes is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Fraser J. Wilkes has authored 7 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Surgery. Recurrent topics in Fraser J. Wilkes's work include Virus-based gene therapy research (3 papers), Muscle Physiology and Disorders (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Fraser J. Wilkes is often cited by papers focused on Virus-based gene therapy research (3 papers), Muscle Physiology and Disorders (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Fraser J. Wilkes collaborates with scholars based in United Kingdom, United States and Italy. Fraser J. Wilkes's co-authors include Susan M. Kingsman, Nicholas D. Mazarakis, Kyriacos Mitrophanous, Lucy E. Walmsley, Mimoun Azzouz, Jonathan B. Rohll, Alan J. Kingsman, Umrao R. Monani, Arthur H.M. Burghes and Liang‐Fong Wong and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Molecular Therapy.

In The Last Decade

Fraser J. Wilkes

7 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fraser J. Wilkes United Kingdom 7 542 353 170 99 64 7 695
Ghiabe-Henri Guibinga United States 15 473 0.9× 231 0.7× 49 0.3× 58 0.6× 20 0.3× 24 586
Todd A. Derksen United States 10 551 1.0× 510 1.4× 40 0.2× 99 1.0× 14 0.2× 10 852
Marie Montus France 8 837 1.5× 662 1.9× 86 0.5× 86 0.9× 12 0.2× 10 1.1k
Colin L. Sweeney United States 15 752 1.4× 286 0.8× 49 0.3× 70 0.7× 11 0.2× 31 1.1k
Julie Dumonceaux France 20 1.1k 2.1× 121 0.3× 289 1.7× 116 1.2× 185 2.9× 47 1.4k
Eric Finn United States 13 862 1.6× 452 1.3× 58 0.3× 65 0.7× 36 0.6× 19 997
S Blanchard France 8 383 0.7× 185 0.5× 26 0.2× 26 0.3× 73 1.1× 8 710
Lin Ye United States 11 738 1.4× 161 0.5× 68 0.4× 25 0.3× 64 1.0× 27 828
Kiyomi Taniguchi Japan 8 757 1.4× 91 0.3× 43 0.3× 125 1.3× 31 0.5× 12 924
William Coley United States 14 532 1.0× 53 0.2× 41 0.2× 112 1.1× 58 0.9× 16 766

Countries citing papers authored by Fraser J. Wilkes

Since Specialization
Citations

This map shows the geographic impact of Fraser J. Wilkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fraser J. Wilkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fraser J. Wilkes more than expected).

Fields of papers citing papers by Fraser J. Wilkes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fraser J. Wilkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fraser J. Wilkes. The network helps show where Fraser J. Wilkes may publish in the future.

Co-authorship network of co-authors of Fraser J. Wilkes

This figure shows the co-authorship network connecting the top 25 collaborators of Fraser J. Wilkes. A scholar is included among the top collaborators of Fraser J. Wilkes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fraser J. Wilkes. Fraser J. Wilkes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Tinsley, Jonathon M., Rebecca J. Fairclough, Richard Storer, et al.. (2011). Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse. PLoS ONE. 6(5). e19189–e19189. 140 indexed citations
2.
Johnson, Peter D., Adam Lambert, R.J. Pye, et al.. (2011). Discovery and SAR of 2-arylbenzotriazoles and 2-arylindazoles as potential treatments for Duchenne muscular dystrophy. Bioorganic & Medicinal Chemistry Letters. 21(16). 4828–4831. 16 indexed citations
3.
Radcliffe, P. A., et al.. (2007). Analysis of factor VIII mediated suppression of lentiviral vector titres. Gene Therapy. 15(4). 289–297. 26 indexed citations
4.
Azzouz, Mimoun, Thanh T. Le, G. Ralph, et al.. (2004). Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. Journal of Clinical Investigation. 114(12). 1726–1731. 157 indexed citations
5.
Azzouz, Mimoun, Thanh T. Le, Lucy E. Walmsley, et al.. (2004). Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. Journal of Clinical Investigation. 114(12). 1726–1731. 11 indexed citations
6.
Wong, Liang‐Fong, Mimoun Azzouz, Lucy E. Walmsley, et al.. (2003). Transduction Patterns of Pseudotyped Lentiviral Vectors in the Nervous System. Molecular Therapy. 9(1). 101–111. 116 indexed citations
7.
Rohll, Jonathan B., et al.. (1999). Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Therapy. 6(11). 1808–1818. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026